Сompared to healthy controls, the decrease of TF IgG in patients with gastric cancer (estimated as a proportion of weak responders) was less pronounced than that of IgM weak responders, thus indicating that the IgG/IgM ratio was lower in gastric cancer, especially in Le b+/secretor phenotype individuals [16]. This evidence concerns the gene TF and gastric cancer.